Nike Isn't Afraid of Competition in the Sneaker Wars
Nike hopes its newest running shoe will help athletes improve their performance, and the company’s vice president of running footwear credits the way the sneaker is manufactured with helping achieve that goal.
“We use computational design, which is informing this pattern that you see on the midsole and outsole, so that’s called our fluid geometry” said Brett Holts in an interview with Cheddar. “What this allows us to do is iterate much quicker.”
“We can take thousands of data inputs from elite athletes, every day runners, our research lab. We can put all those inputs into a computer program, and it spits out an algorithm that gives us this fluid geometry.”
But the competition is heating up. Last year Adidas, which touts its own BOOST technology, overtook Nike’s Michael Jordan-fronted line as the #2 brand in U.S. sports footwear.
Holts, though, isn’t intimidated.
“We feel like [competition] continues to push us, continues to keep us sharp,” he said.
The Nike Epic React Flyknit will be available on February 22 and cost $150.
For full interview [click here](https://cheddar.com/videos/inside-nikes-newest-innovation).
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
